Peptides

Retatrutide represents a significant milestone in metabolic research. Unlike earlier incretin-based molecules that target one or two receptors, retatrutide is a “triple agonist,” engineered to simultaneously activate receptors for GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon. As of 2026, retatrutide remains an investigational molecule, evaluated in Phase 3 clinical programs (e.g. TRIUMPH, TRANSCEND-T2D)….

BPC-157 (Body Protection Compound-157) is a synthetic peptide fragment derived from a protective protein found in gastric juice. It has drawn significant attention in the research community for its studied roles in tissue repair and cytoprotection. This guide reviews what BPC-157 is, the mechanisms researchers study, and the state of the evidence. All information is…

Welcome to Nuvion Peptides, your trusted source for high-quality research peptides in Canada. This pillar guide gives an in-depth overview of research peptides and links to our full library of compound-specific research guides — a complete map of the peptides Canadian laboratories study most. What are peptides? Peptides are short chains of amino acids, the…